Fangfang Chen, Xingchen Du, Li Zhao, Weiguo Wan, Hejian Zou, Xue Yu
{"title":"高尿酸血症患者肾脏受累模型的开发与验证:横断面研究","authors":"Fangfang Chen, Xingchen Du, Li Zhao, Weiguo Wan, Hejian Zou, Xue Yu","doi":"10.1111/1756-185X.15374","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>To construct a prediction model for renal involvement in patients with hyperuricemia (HUA) based on logistic regression analysis, to achieve early risk stratification.</p>\n </section>\n \n <section>\n \n <h3> Method</h3>\n \n <p>In this cross-sectional study, we collected data from the National Health and Nutrition Examination Survey (NHANES), and constructed a predicted model for renal involvement in HUA patients. The discriminative ability of the model was assessed using the receiver operating characteristic (ROC) curve. Model accuracy was evaluated using the Hosmer-Lemeshow test and calibration curve, while clinical utility was assessed using decision curve analysis (DCA). Furthermore, internal and external validation cohorts were also applied to validate the model.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>A total of 1669 patients from NHANES between 2007 and 2010 were included in the final analysis for modeling and validation. Six predictive factors including age, Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Cr, Uric Acid (UA), and sex were identified by binary logistic regression analysis for renal involvement in HUA patients and used to construct a nomogram with good consistency and accuracy. The AUC values for the predictive model, internal validation, and external validation were 0.881 (95% CI: 0.836–0.926), 0.908 (95% CI: 0.871–0.944), and 0.927 (95% CI: 0.897–0.957), respectively. The calibration curves demonstrated consistency between the nomogram and observed values. The DCA curves of the model and validation cohort indicated good clinical utility.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>This study developed a predictive model for renal involvement in hyperuricemia patients with strong predictive performance and validated by internal and external cohorts, aiding in the early detection of high-risk populations for renal involvement.</p>\n </section>\n </div>","PeriodicalId":14330,"journal":{"name":"International Journal of Rheumatic Diseases","volume":"27 11","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development and validation of a renal involvement model for patients with hyperuricemia: A cross-sectional study\",\"authors\":\"Fangfang Chen, Xingchen Du, Li Zhao, Weiguo Wan, Hejian Zou, Xue Yu\",\"doi\":\"10.1111/1756-185X.15374\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Objective</h3>\\n \\n <p>To construct a prediction model for renal involvement in patients with hyperuricemia (HUA) based on logistic regression analysis, to achieve early risk stratification.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Method</h3>\\n \\n <p>In this cross-sectional study, we collected data from the National Health and Nutrition Examination Survey (NHANES), and constructed a predicted model for renal involvement in HUA patients. The discriminative ability of the model was assessed using the receiver operating characteristic (ROC) curve. Model accuracy was evaluated using the Hosmer-Lemeshow test and calibration curve, while clinical utility was assessed using decision curve analysis (DCA). Furthermore, internal and external validation cohorts were also applied to validate the model.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>A total of 1669 patients from NHANES between 2007 and 2010 were included in the final analysis for modeling and validation. Six predictive factors including age, Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Cr, Uric Acid (UA), and sex were identified by binary logistic regression analysis for renal involvement in HUA patients and used to construct a nomogram with good consistency and accuracy. The AUC values for the predictive model, internal validation, and external validation were 0.881 (95% CI: 0.836–0.926), 0.908 (95% CI: 0.871–0.944), and 0.927 (95% CI: 0.897–0.957), respectively. The calibration curves demonstrated consistency between the nomogram and observed values. The DCA curves of the model and validation cohort indicated good clinical utility.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>This study developed a predictive model for renal involvement in hyperuricemia patients with strong predictive performance and validated by internal and external cohorts, aiding in the early detection of high-risk populations for renal involvement.</p>\\n </section>\\n </div>\",\"PeriodicalId\":14330,\"journal\":{\"name\":\"International Journal of Rheumatic Diseases\",\"volume\":\"27 11\",\"pages\":\"\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Rheumatic Diseases\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.15374\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RHEUMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Rheumatic Diseases","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.15374","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
Development and validation of a renal involvement model for patients with hyperuricemia: A cross-sectional study
Objective
To construct a prediction model for renal involvement in patients with hyperuricemia (HUA) based on logistic regression analysis, to achieve early risk stratification.
Method
In this cross-sectional study, we collected data from the National Health and Nutrition Examination Survey (NHANES), and constructed a predicted model for renal involvement in HUA patients. The discriminative ability of the model was assessed using the receiver operating characteristic (ROC) curve. Model accuracy was evaluated using the Hosmer-Lemeshow test and calibration curve, while clinical utility was assessed using decision curve analysis (DCA). Furthermore, internal and external validation cohorts were also applied to validate the model.
Results
A total of 1669 patients from NHANES between 2007 and 2010 were included in the final analysis for modeling and validation. Six predictive factors including age, Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Cr, Uric Acid (UA), and sex were identified by binary logistic regression analysis for renal involvement in HUA patients and used to construct a nomogram with good consistency and accuracy. The AUC values for the predictive model, internal validation, and external validation were 0.881 (95% CI: 0.836–0.926), 0.908 (95% CI: 0.871–0.944), and 0.927 (95% CI: 0.897–0.957), respectively. The calibration curves demonstrated consistency between the nomogram and observed values. The DCA curves of the model and validation cohort indicated good clinical utility.
Conclusion
This study developed a predictive model for renal involvement in hyperuricemia patients with strong predictive performance and validated by internal and external cohorts, aiding in the early detection of high-risk populations for renal involvement.
期刊介绍:
The International Journal of Rheumatic Diseases (formerly APLAR Journal of Rheumatology) is the official journal of the Asia Pacific League of Associations for Rheumatology. The Journal accepts original articles on clinical or experimental research pertinent to the rheumatic diseases, work on connective tissue diseases and other immune and allergic disorders. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor.